Geng Meiyu (6th R), key inventor of the drug GV-971, also a researcher of Shanghai Institute of Materia Medica under Chinese Academy of Sciences, poses for a group photo with her team at the Green Valley institute in Shanghai, east China, Nov. 3, 2019. A home-grown drug for treating Alzheimer's disease has been approved by the National Medical Products Administration to hit the market, according to its developers Saturday. The drug, GV-971, was developed by Ocean University of China, Shanghai Institute of Materia Medica under Chinese Academy of Sciences and Green Valley Pharmaceutical Co., Ltd, after research efforts of 22 years. (Xinhua/Jin Liwang)
 |  |
Award-winning photos show poverty reduction achievements in NE China's Jilin province
People dance to greet advent of New Year in Ameiqituo Town, Guizhou
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
